Maylan Laboratories Limited (OTL)

The drug is used to treat breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

Dosage form: concentrate for infusion solution

ATC: L01CD02

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs, such as 5-fluorouracil and folinic acid).

Dosage form: concentrate for infusion solution

ATC: L01XA03

The drug is used for the chemotherapy of ovarian cancer, breast cancer, advanced non-small cell lung cancer, as well as for the therapy of Kaposi's sarcoma in patients with AIDS.

Dosage form: concentrate for infusion solution

ATC: L01CD01

The drug is used to treat a wide range of neoplasms, including breast cancer, lung cancer, stomach cancer, liver cancer, pancreatic cancer, rectal cancer, ovarian cancer, as well as malignant lymphomas, soft tissue sarcomas, and leukemia. It is also used for the treatment of superficial bladder cancer.

Dosage form: solution for injection

ATC: L01DB03

The drug is used both as monotherapy and in combination with other agents for epithelial ovarian cancer and small cell lung cancer.

Dosage form: solution for infusion

ATC: L01XA02

The drug is used for the treatment of bladder cancer, pancreatic cancer, non-small cell lung cancer, ovarian cancer, breast cancer, and bile duct cancer.

Dosage form: powder for solution for infusion

ATC: L01BC05

The drug is used for the treatment of bladder cancer, pancreatic cancer, non-small cell lung cancer, ovarian cancer, breast cancer, and bile duct cancer.

Dosage form: powder for solution for infusion

ATC: L01BC05